Deoxymethoxetamine
Chemical compound
- CA: Schedule I
- DE: NpSG (Industrial and scientific use only)
- UK: Class B
- 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one
- 2666932-45-0
- 157010705
- G32GTT7MGW
- Interactive image
- CCNC1(CCCCC1=O)c1cccc(C)c1
InChI
- InChI=1S/C15H21NO/c1-3-16-15(10-5-4-9-14(15)17)13-8-6-7-12(2)11-13/h6-8,11,16H,3-5,9-10H2,1-2H3
- Key:WIMLPRYZJQNQLE-UHFFFAOYSA-N
Deoxymethoxetamine (3'-methyl-2-oxo-PCE, DMXE, 3D-MXE) is a recreational designer drug from the arylcyclohexylamine family, with dissociative effects. It is an analogue of methoxetamine where the 3-methoxy group has been replaced by methyl. It has been sold online since around October 2020, and was first definitively identified by a forensic laboratory in Denmark in February 2021.[1][2]
See also
- 3-Methyl-PCP
- 3-Methyl-PCPy
- Hydroxetamine
- Fluorexetamine
- Methoxetamine
- Methoxieticyclidine
- MXiPr
References
- ^ "Alert from NDEWS Web Monitoring team: Increases in Reddit discussions of DMXE October 2020–March 2021". National Drug Early Warning System (28). University of Florida, funded by the National Institute on Drug Abuse. 26 March 2021.
- ^ Skinnider M, Wang F, Pasin D, Greiner R, Foster L, Dalsgaard P, Wishart DS (2021). "A Deep Generative Model Enables Automated Structure Elucidation of Novel Psychoactive Substances". ChemRxiv. Cambridge: Cambridge Open Engage.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
